Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08

Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08–02 study

Published:2023-05 Issue: Volume: Page:101506
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Gendarme Sébastien,Zebachi Sonia,Corre Romain,Greillier Laurent,Justeau Grégoire,Bylicki Olivier,Decroisette Chantal,Auliac Jean-Bernard,Guisier Florian,Geier Margaux,Ricordel Charles,Frelaut Maxime,Paillaud Elena,Chouaïd Christos,Canouï-Poitrine Florence

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference51 articles.

1. Source: ECIS - European Cancer Information System From https://ecis.jrc.ec.europa.eu, accessed on 28/07/2022 © European Union, 2023 n.d.

2. Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Planchard;Ann Oncol,2018

3. Management of elderly patients with NSCLC; updated expert’s opinion paper: EORTC elderly task force, lung cancer group and international society for geriatric oncology;Pallis;Ann Oncol,2014

4. Basic assessment of the older cancer patient;Extermann;Curr Treat Options Oncol,2011

5. Enrollment of elderly patients in clinical trials for cancer drug registration: a 7-year experience by the US Food and Drug Administration;Talarico;J Clin Oncol,2004

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. First-line durvalumab in patients with PD-L1 positive, advanced non-small cell lung cancer (NSCLC) with a performance status of 2 (PS2). Primary analysis of the multicenter, single-arm phase II trial SAKK 19/17;European Journal of Cancer;2024-03

2. Cancer rarely travels alone: Addressing the accumulation of risk and early mortality for older adults with advanced lung cancer;Journal of Geriatric Oncology;2023-07